|
|
| Word Search |
Astellas Announces Changing Tomorrow Day To Support Action in Local Communities -Part1-
Astellas Pharma
(September 08, 2010)
|
Donation of Ambulances on First-Aid Day (September 9)
Astellas Pharma
(September 08, 2010)
|
SymBio and Eisai to Launch Symbenda® (Bendamustine Hydrochloride) in Singapore for the Treatment of Low-grade Non-Hodgkin’s Lymphoma and Chronic Lymphatic Leukemia
Eisai
(September 07, 2010)
|
SymBio and Eisai to Launch Symbenda® (Bendamustine Hydrochloride) in Singapore for the Treatment of Low-grade Non-Hodgkin’s Lymphoma and Chronic Lymphatic Leukemia
SymBio Pharmaceuticals
(September 07, 2010)
|
Daily Market Movers (3 Sep 2010)
(September 06, 2010)
|
| Daily Market Movers (2 Sep 2010)
(September 03, 2010)
|
Seattle Genetics Achieves Milestone under Antibody-Drug Conjugate Collaboration with Agensys, an Affiliate of Astellas
Seattle Genetics
(September 02, 2010)
|
Agensys, an Affiliate of Astellas, Announces Initiation of Phase I Clinical Trial of AGS-16M8F for Renal Cancer
Astellas Pharma
(September 01, 2010)
|
Basilea Reports 2010 Interim Results
Basilea Pharmaceutica
(August 19, 2010)
|
Memorandum of Understandings for UMN Pharma’s Cell Culture Based Influenza Vaccine Programs in Japan
Astellas Pharma
(August 17, 2010)
|
|
|
|
|
|
|
|